Showing results (191-200 of 890) with videos related to

Sort By:
Pageof 89
Contemporary Oncology (Poznan, Poland)|October 18, 2024
Performance of ChatGPT in providing patient information about upper tract urothelial carcinomaJan Łaszkiewicz, Wojciech Krajewski, Wojciech Tomczak, et al.
Contemporary Oncology (Poznan, Poland)|May 27, 2024
Deep feature extraction and fine κ-nearest neighbour for enhanced human papillomavirus detection in cervical cancer - a comprehensive analysis of colposcopy imagesLipsarani Jena, Santi Kumari Behera, Srikanta Dash, et al.
Contemporary Oncology (Poznan, Poland)|May 27, 2024
Application of nitroxoline in urologic oncology - a review of evidenceWojciech Andrzej Tomczak, Wojciech Krajewski, Joanna Chorbińska, et al.
Contemporary Oncology (Poznan, Poland)|February 12, 2025
Cytotoxicity of gold nanoparticles to human lymphocytes: a comparison between rod-shaped and spherical nanoparticlesJacek Sikora, Paulina Błaszkiewicz, Alina Dudkowiak, et al.
Contemporary Oncology (Poznan, Poland)|January 19, 2024
Virtual docking screening and quantitative structure-activity relationship studies to explore AKT and PI3K inhibitors acting on mTOR in cancers by theoretical biology and medical modelingIlham Kandoussi, Hanane Abbou, Ghyzlane El Haddoumi, et al.
Contemporary Oncology (Poznan, Poland)|January 19, 2024
An elevated systemic inflammation index is related to an inferior response to pomalidomide and dexamethasone treatment in patients with relapsed and refractory multiple myelomaDamian Mikulski, Paweł Robak, Grzegorz Mirocha, et al.
Contemporary Oncology (Poznan, Poland)|January 19, 2024
Potential antitumour effect of all-trans retinoic acid on regorafenib-treated human colon cancer cell linesMariam Hamad, Radwa Ali Mehana, Mohammad M Abd-Al Haseeb, et al.
Contemporary Oncology (Poznan, Poland)|January 19, 2024
NamiRNA-mediated high expression of KNSTRN correlates with poor prognosis and immune infiltration in hepatocellular carcinomaLiang Jin, Xiaojing Zhang, Ming Fan, et al.
Contemporary Oncology (Poznan, Poland)|January 19, 2024
Altered immunoexpression of DNA polymerase delta 1 catalytic subunit (POLD1) in colorectal cancerPrzemysław Stefaniak, Bartłomiej Emil Kraziński, Jacek Kieżun, et al.
Contemporary Oncology (Poznan, Poland)|February 26, 2024
High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening TrialRafal Dziadziuszko, Nir Peled, Tony Mok, et al.
Pageof 89